These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 31611852)
1. The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell. Hua C; Zhu Y; Wu C; Si L; Wang Q; Sui L; Jiang S Front Microbiol; 2019; 10():2188. PubMed ID: 31611852 [TBL] [Abstract][Full Text] [Related]
2. A clinically used anti-human papilloma virus agent (3-hydroxyphthalic anhydride-modified bovine β-lactoglobulin) has a potential for topical application to prevent sexual transmission of monkeypox virus. Sha Y; Huang B; Hua C; Zhu Y; Tai W; Sun J; Li Y; Xia A; Wang Q; Lu L; Tan W; Jiang S MedComm (2020); 2024 Aug; 5(8):e677. PubMed ID: 39105195 [TBL] [Abstract][Full Text] [Related]
3. Chemically Modified Bovine β-Lactoglobulin as a Broad-Spectrum Influenza Virus Entry Inhibitor with the Potential to Combat Influenza Outbreaks. Fu Y; Li P; Xu W; Liu Z; Wang C; Wang Q; Tang J; Li W; Lu L; Jiang S Viruses; 2022 Sep; 14(9):. PubMed ID: 36146861 [TBL] [Abstract][Full Text] [Related]
4. 3-Hydroxyphthaloyl beta-lactoglobulin. IV Antiviral activity in the mouse model of genital herpesvirus infection. Kokuba H; Aurelian L; Neurath AR Antivir Chem Chemother; 1998 Jul; 9(4):353-7. PubMed ID: 9875414 [TBL] [Abstract][Full Text] [Related]
5. 3-Hydroxyphthaloyl beta-lactoglobulin. III. Antiviral activity against herpesviruses. Neurath AR; Strick N; Li YY Antivir Chem Chemother; 1998 Mar; 9(2):177-84. PubMed ID: 9875389 [TBL] [Abstract][Full Text] [Related]
6. Bovine beta-lactoglobulin modified by 3-hydroxyphthalic anhydride blocks the CD4 cell receptor for HIV. Neurath AR; Jiang S; Strick N; Lin K; Li YY; Debnath AK Nat Med; 1996 Feb; 2(2):230-4. PubMed ID: 8574970 [TBL] [Abstract][Full Text] [Related]
7. Effect of 3-hydroxyphthaloyl-beta-lactoglobulin on vaginal transmission of simian immunodeficiency virus in rhesus monkeys. Wyand MS; Manson KH; Miller CJ; Neurath AR Antimicrob Agents Chemother; 1999 Apr; 43(4):978-80. PubMed ID: 10103216 [TBL] [Abstract][Full Text] [Related]
8. Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission. Li L; Qiao P; Yang J; Lu L; Tan S; Lu H; Zhang X; Chen X; Wu S; Jiang S; Liu S Retrovirology; 2010 Apr; 7():37. PubMed ID: 20420669 [TBL] [Abstract][Full Text] [Related]
9. Glycodelins GdA and GdS modified by 3-hydroxyphthalic anhydride inhibit gp120-CD4 binding and HIV-1 infection in vitro. Seppälä M; Jiang S; Strick N; Lin K; Li YY; Koistinen H; Koistinen R; Neurath AR Lab Invest; 1997 Aug; 77(2):127-30. PubMed ID: 9274854 [TBL] [Abstract][Full Text] [Related]
10. Structural and functional analysis of negatively charged milk proteins with anti-HIV activity. Berkhout B; Derksen GC; Back NK; Klaver B; de Kruif CG; Visser S AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1101-7. PubMed ID: 9282815 [TBL] [Abstract][Full Text] [Related]
11. Cutaneous and mucosal human papillomaviruses differ in net surface charge, potential impact on tropism. Mistry N; Wibom C; Evander M Virol J; 2008 Oct; 5():118. PubMed ID: 18854037 [TBL] [Abstract][Full Text] [Related]
12. Safety evaluation of chemically modified beta-lactoglobulin administered intravaginally. Guo X; Qiu L; Wang Y; Wang Y; Meng Y; Zhu Y; Lu L; Jiang S J Med Virol; 2016 Jun; 88(6):1098-101. PubMed ID: 26629967 [TBL] [Abstract][Full Text] [Related]
13. Interferon Gamma Prevents Infectious Entry of Human Papillomavirus 16 via an L2-Dependent Mechanism. Day PM; Thompson CD; Lowy DR; Schiller JT J Virol; 2017 May; 91(10):. PubMed ID: 28250129 [TBL] [Abstract][Full Text] [Related]
14. Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus types. Kwak K; Jiang R; Wang JW; Jagu S; Kirnbauer R; Roden RB PLoS One; 2014; 9(5):e97232. PubMed ID: 24816794 [TBL] [Abstract][Full Text] [Related]
15. The Cytoskeletal Adaptor Obscurin-Like 1 Interacts with the Human Papillomavirus 16 (HPV16) Capsid Protein L2 and Is Required for HPV16 Endocytosis. Wüstenhagen E; Hampe L; Boukhallouk F; Schneider MA; Spoden GA; Negwer I; Koynov K; Kast WM; Florin L J Virol; 2016 Dec; 90(23):10629-10641. PubMed ID: 27654294 [TBL] [Abstract][Full Text] [Related]
16. Chemically modified bovine beta-lactoglobulin inhibits human papillomavirus infection. Lu L; Yang X; Li Y; Jiang S Microbes Infect; 2013 Jun; 15(6-7):506-10. PubMed ID: 23518265 [TBL] [Abstract][Full Text] [Related]
17. Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection. Liu X; Chen J; Wang Z; Wang D; He M; Qian C; Song S; Chi X; Kong Z; Zheng Q; Wang Y; Yu H; Zhao Q; Zhang J; Li S; Gu Y; Xia N Emerg Microbes Infect; 2019; 8(1):1721-1733. PubMed ID: 31769733 [TBL] [Abstract][Full Text] [Related]
18. Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16. Chen J; Wang D; Wang Z; Wu K; Wei S; Chi X; Qian C; Xu Y; Zhou L; Li Y; Zhang S; Li T; Kong Z; Wang Y; Zheng Q; Yu H; Zhao Q; Zhang J; Xia N; Li S; Gu Y J Virol; 2023 Mar; 97(3):e0181922. PubMed ID: 36815785 [TBL] [Abstract][Full Text] [Related]